Cargando…

Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas

BACKGROUND: Chagas disease constitutes an important public health threat in terms of morbidity and mortality in the areas in the United States where immigrant populations from Latin America are conspicuous. We conducted a survey to assess the prevalence of anti-T. cruzi antibody in Hispanic-surnamed...

Descripción completa

Detalles Bibliográficos
Autores principales: Arena, Roberto, Mathews, Christine E, Kim, Anne Y, Lenz, Tim E, Southern, Paul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108937/
https://www.ncbi.nlm.nih.gov/pubmed/21529355
http://dx.doi.org/10.1186/1756-0500-4-132
_version_ 1782205388992544768
author Arena, Roberto
Mathews, Christine E
Kim, Anne Y
Lenz, Tim E
Southern, Paul M
author_facet Arena, Roberto
Mathews, Christine E
Kim, Anne Y
Lenz, Tim E
Southern, Paul M
author_sort Arena, Roberto
collection PubMed
description BACKGROUND: Chagas disease constitutes an important public health threat in terms of morbidity and mortality in the areas in the United States where immigrant populations from Latin America are conspicuous. We conducted a survey to assess the prevalence of anti-T. cruzi antibody in Hispanic-surnamed patients seen at Parkland Memorial Hospital in Dallas, Texas. FINDINGS: Five hundred serum specimens from Hispanic-surnamed patients were tested by a preliminary ELISA method. On a subset of 50 sera confirmatory testing was also performed using an alternative ELISA, indirect immunofluorescence, and TESA immunoblot. For 274 of 500 Hispanic-surnamed patients, we were able to ascertain immigration status upon medical chart review. Of the 274 sera analyzed, one sample tested as positive for anti-T. cruzi antibody by the preliminary ELISA, and by the three confirmatory methods. CONCLUSIONS: The goal of this study is to increase the awareness of T. cruzi infection and Chagas disease in areas where the Latin American immigrant communities are growing. Our study highlights the importance of testing for Chagas disease in the populations most at risk, and the need for current data on the actual seroprevalence in areas where such immigrant populations are conspicuous. Larger-scale epidemiologic surveys on Chagas disease in the immigrant communities from Latin America are warranted.
format Online
Article
Text
id pubmed-3108937
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31089372011-06-07 Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas Arena, Roberto Mathews, Christine E Kim, Anne Y Lenz, Tim E Southern, Paul M BMC Res Notes Short Report BACKGROUND: Chagas disease constitutes an important public health threat in terms of morbidity and mortality in the areas in the United States where immigrant populations from Latin America are conspicuous. We conducted a survey to assess the prevalence of anti-T. cruzi antibody in Hispanic-surnamed patients seen at Parkland Memorial Hospital in Dallas, Texas. FINDINGS: Five hundred serum specimens from Hispanic-surnamed patients were tested by a preliminary ELISA method. On a subset of 50 sera confirmatory testing was also performed using an alternative ELISA, indirect immunofluorescence, and TESA immunoblot. For 274 of 500 Hispanic-surnamed patients, we were able to ascertain immigration status upon medical chart review. Of the 274 sera analyzed, one sample tested as positive for anti-T. cruzi antibody by the preliminary ELISA, and by the three confirmatory methods. CONCLUSIONS: The goal of this study is to increase the awareness of T. cruzi infection and Chagas disease in areas where the Latin American immigrant communities are growing. Our study highlights the importance of testing for Chagas disease in the populations most at risk, and the need for current data on the actual seroprevalence in areas where such immigrant populations are conspicuous. Larger-scale epidemiologic surveys on Chagas disease in the immigrant communities from Latin America are warranted. BioMed Central 2011-04-29 /pmc/articles/PMC3108937/ /pubmed/21529355 http://dx.doi.org/10.1186/1756-0500-4-132 Text en Copyright ©2011 Arena et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Arena, Roberto
Mathews, Christine E
Kim, Anne Y
Lenz, Tim E
Southern, Paul M
Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas
title Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas
title_full Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas
title_fullStr Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas
title_full_unstemmed Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas
title_short Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas
title_sort prevalence of antibody to trypanosoma cruzi in hispanic-surnamed patients seen at parkland health & hospital system, dallas, texas
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108937/
https://www.ncbi.nlm.nih.gov/pubmed/21529355
http://dx.doi.org/10.1186/1756-0500-4-132
work_keys_str_mv AT arenaroberto prevalenceofantibodytotrypanosomacruziinhispanicsurnamedpatientsseenatparklandhealthhospitalsystemdallastexas
AT mathewschristinee prevalenceofantibodytotrypanosomacruziinhispanicsurnamedpatientsseenatparklandhealthhospitalsystemdallastexas
AT kimanney prevalenceofantibodytotrypanosomacruziinhispanicsurnamedpatientsseenatparklandhealthhospitalsystemdallastexas
AT lenztime prevalenceofantibodytotrypanosomacruziinhispanicsurnamedpatientsseenatparklandhealthhospitalsystemdallastexas
AT southernpaulm prevalenceofantibodytotrypanosomacruziinhispanicsurnamedpatientsseenatparklandhealthhospitalsystemdallastexas